Extracellular vesicle therapeutics for liver disease

被引：93

作者：

Borrelli, David A. ^{[1
]}

Yankson, Kiera ^{[1
]}

Shukla, Neha ^{[1
]}

Vilanilam, George ^{[1
]}

Ticer, Taylor ^{[1
]}

Wolfram, Joy ^{[1
,2
,3
,4
]}

机构：

[1] Mayo Clin, Dept Transplantat, 4500 San Pablo Rd, Jacksonville, FL 32224 USA

[2] Houston Methodist Res Inst, Dept Nanomed, Houston, TX 77030 USA

[3] Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA

[4] Chinese Acad Sci, Ningbo Inst Ind Technol, Wenzhou Inst Biomat & Engn, Wenzhou, Peoples R China

来源：

JOURNAL OF CONTROLLED RELEASE | 2018年 / 273卷

关键词：

Extracellular vesicle; Exosome; Liver; Mesenchymal stem cell; Nanovesicle; MESENCHYMAL STEM-CELLS; ISCHEMIA-REPERFUSION INJURY; MSC-DERIVED EXOSOMES; STROMAL CELLS; B16BL6-DERIVED EXOSOMES; MEMBRANE-VESICLES; OXIDATIVE STRESS; KUPFFER CELLS; INFARCT SIZE; IN-VITRO;

D O I：

10.1016/j.jconrel.2018.01.022

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Extracellular vesicles (EVs) are endogenous nanoparticles that play important roles in intercellular communication. Unmodified and engineered EVs can be utilized for therapeutic purposes. For instance, mesenchymal stem cell (MSC)-derived EVs have shown promise for tissue repair, while drug-loaded EVs have the potential to be used for cancer treatment. The liver is an ideal target for EV therapy due to the intrinsic regenerative capacity of hepatic tissue and the tropism of systemically injected nanovesicles for this organ. This review will give an overview of the potential of EV therapeutics in liver disease. Specifically, the mechanisms by which MSC-EVs induce liver repair will be covered. Moreover, the use of drug-loaded EVs for the treatment of hepatocellular carcinoma will also be discussed. Although there are several challenges associated with the clinical translation of EVs, these biological nanoparticles represent a promising new therapeutic modality for liver disease.

引用

页码：86 / 98

页数：13

共 145 条

[1] Neoplastic Reprogramming of Patient-Derived Adipose Stem Cells by Prostate Cancer Cell-Associated Exosomes [J].

Abd Elmageed, Zakaria Y. ;

Yang, Yijun ;

Thomas, Raju ;

Ranjan, Manish ;

Mondal, Debasis ;

Moroz, Krzysztof ;

Fang, Zhide ;

Rezk, Bashir M. ;

Moparty, Krishnarao ;

Sikka, Suresh C. ;

Sartor, Oliver ;

Abdel-Mageed, Asim B. .

STEM CELLS, 2014, 32 (04) :983-997

[2] Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes [J].

Aga, M. ;

Bentz, G. L. ;

Raffa, S. ;

Torrisi, M. R. ;

Kondo, S. ;

Wakisaka, N. ;

Yoshizaki, T. ;

Pagano, J. S. ;

Shackelford, J. .

ONCOGENE, 2014, 33 (37) :4613-4622

[3] Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].

Alvarez-Erviti, Lydia ;

Seow, Yiqi ;

Yin, HaiFang ;

Betts, Corinne ;

Lakhal, Samira ;

Wood, Matthew J. A. .

NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179

[4] VESICLES ASSOCIATED WITH CALCIFICATION IN MATRIX OF EPIPHYSEAL CARTILAGE [J].

ANDERSON, HC .

JOURNAL OF CELL BIOLOGY, 1969, 41 (01) :59-+

[5] Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury [J].

Arslan, Fatih ;

Lai, Ruenn Chai ;

Smeets, Mirjam B. ;

Akeroyd, Lars ;

Choo, Andre ;

Aguor, Eissa N. E. ;

Timmers, Leo ;

van Rijen, Harold V. ;

Doevendans, Pieter A. ;

Pasterkamp, Gerard ;

Lim, Sai Kiang ;

de Kleijn, Dominique P. .

STEM CELL RESEARCH, 2013, 10 (03) :301-312

[6]

ASSI R, 2016, BLOOD, V128

[7] Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy [J].

Aubertin, Kelly ;

Silva, Amanda K. A. ;

Luciani, Nathalie ;

Espinosa, Ana ;

Djemat, Aurelie ;

Charue, Dominique ;

Gallet, Francois ;

Blanc-Brude, Olivier ;

Wilhelm, Claire .

SCIENTIFIC REPORTS, 2016, 6

[8] Integrins in angiogenesis and lymphangiogenesis [J].

Avraamides, Christie J. ;

Garmy-Susini, Barbara ;

Varner, Judith A. .

NATURE REVIEWS CANCER, 2008, 8 (08) :604-617

[9] Doxil® - The first FDA-approved nano-drug: Lessons learned [J].

Barenholz, Yechezkel .

JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134

[10] Liver fibrosis [J].

Bataller, R ;

Brenner, DA .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218

← 1 2 3 4 5 6 7 8 9 10 →